DXCM (DexCom, Inc.) Stock Financials & Earnings | Market Cap Arena

DXCM (DexCom, Inc.) Stock Financials & Earnings | Market Cap Arena

DXCMDexCom, Inc.

Mkt Cap$27B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$4.7B

Net Income (TTM)$836M

EPS (TTM)$2.09

Free Cash Flow (TTM)$1.1B

Gross Margin60.1%

Op. Margin19.6%

Net Margin17.9%

FCF Margin23.1%

P/S Ratio (TTM)5.7x

P/E Ratio (TTM)31.7x

YoY Rev Growth+15.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$742M	$463M	$47M
Q2 23	$871M	$546M	$128M
Q3 23	$975M	$623M	$206M
Q4 23	$1.0B	$657M	$217M
Q1 24	$921M	$562M	$101M
Q2 24	$1.0B	$627M	$158M
Q3 24	$994M	$594M	$152M
Q4 24	$1.1B	$656M	$189M
Q1 25	$1.0B	$589M	$134M
Q2 25	$1.2B	$689M	$213M
Q3 25	$1.2B	$731M	$243M
Q4 25	$1.3B	$793M	$323M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	8.8x	90.7x
Q2 23	8.3x	74.2x
Q3 23	7.8x	70.3x
Q4 23	7.3x	49.0x
Q1 24	7.0x	41.5x
Q2 24	6.7x	39.8x
Q3 24	6.7x	39.0x
Q4 24	6.6x	46.0x
Q1 25	6.4x	49.5x
Q2 25	6.2x	46.4x
Q3 25	5.9x	36.8x
Q4 25	5.7x	31.7x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$155M	$81M
Q2 23	$190M	$131M
Q3 23	$269M	$219M
Q4 23	$134M	$81M
Q1 24	$209M	$152M
Q2 24	$279M	$213M
Q3 24	$200M	$88M
Q4 24	$301M	$177M
Q1 25	$184M	$97M
Q2 25	$303M	$209M
Q3 25	$660M	$579M
Q4 25	$294M	$192M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$75M
Q2 23	$59M
Q3 23	$50M
Q4 23	$53M
Q1 24	$57M
Q2 24	$66M
Q3 24	$111M
Q4 24	$125M
Q1 25	$87M
Q2 25	$94M
Q3 25	$81M
Q4 25	$102M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+17.9%	+18.2%
Q2 23	+25.2%	+20.0%
Q3 23	+26.7%	+23.7%
Q4 23	+26.9%	+18.5%
Q1 24	+24.2%	+18.1%
Q2 24	+15.3%	+13.9%
Q3 24	+2.0%	+9.4%
Q4 24	+7.6%	+13.1%
Q1 25	+12.5%	+10.1%
Q2 25	+15.2%	+11.6%
Q3 25	+21.6%	+14.8%
Q4 25	+13.1%	+1.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$35M	4.7%
Q2 23	$40M	4.6%
Q3 23	$39M	4.0%
Q4 23	$37M	3.6%
Q1 24	$39M	4.2%
Q2 24	$45M	4.5%
Q3 24	$43M	4.4%
Q4 24	$43M	3.9%
Q1 25	$34M	3.3%
Q2 25	$45M	3.9%
Q3 25	$45M	3.7%
Q4 25	$35M	2.8%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$119M	$296M
Q2 23	$119M	$299M
Q3 23	$131M	$286M
Q4 23	$136M	$309M
Q1 24	$142M	$319M
Q2 24	$136M	$333M
Q3 24	$135M	$306M
Q4 24	$140M	$327M
Q1 25	$145M	$310M
Q2 25	$148M	$328M
Q3 25	$158M	$331M
Q4 25	$148M	$322M

Revenue by Geography

Quarter	Non-US	United States
Q1 23	$216M	$526M
Q2 23	$255M	$617M
Q3 23	$261M	$714M
Q4 23	$265M	$769M
Q1 24	$268M	$653M
Q2 24	$272M	$732M
Q3 24	$292M	$702M
Q1 25	$286M	$751M
Q2 25	$316M	$841M
Q3 25	$357M	$852M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$623M	$1.9B	$2.6B
Q2 23	$1.2B	$2.4B	$3.6B
Q3 23	$644M	$2.6B	$3.2B
Q4 23	$566M	$2.2B	$2.7B
Q1 24	$851M	$2.0B	$2.9B
Q2 24	$939M	$2.2B	$3.1B
Q3 24	$621M	$1.9B	$2.5B
Q4 24	$606M	$2.0B	$2.6B
Q1 25	$905M	$1.8B	$2.7B
Q2 25	$1.2B	$1.8B	$2.9B
Q3 25	$1.8B	$1.5B	$3.3B
Q4 25	$918M	$1.1B	$2.0B

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	419M	-1.7%
Q2 23	432M	+3.1%
Q3 23	427M	-1.1%
Q4 23	416M	-2.6%
Q1 24	417M	+0.2%
Q2 24	417M	+0.0%
Q3 24	410M	-1.6%
Q4 24	407M	-0.9%
Q1 25	408M	+0.2%
Q2 25	408M	+0.2%
Q3 25	407M	-0.2%
Q4 25	399M	-2.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$309K	838
FY 15	$332K	1K
FY 16	$302K	2K
FY 17	$314K	2K
FY 18	$368K	3K
FY 19	$378K	4K
FY 20	$350K	6K
FY 21	$389K	6K
FY 22	$383K	8K
FY 23	$377K	10K
FY 24	$420K	10K
FY 25	$420K	11K